Recombinant adeno-associated virus virus-derived vectors (rAAVs) are among the most used viral delivery system for in vivo gene therapies with a good safety profile. However, rAAV production methods often lead to a heterogeneous vector population, in particular with the presence of undesired empty particles. Analytical ultracentrifugation sedimentation velocity (AUC-SV) is considered as the gold analytical technique allowing the measurement of relative amounts of each vector subpopulation and components like particle aggregates, based on their sedimentation coefficients. This letter presents the principle and practice of AUC experiments for rAAVs characterization. We discuss our results in the framework of previously published works. In add...
International audienceGene therapy approaches using recombinant adeno-associated virus serotype 2 (r...
Quantifying the composition of viral vectors used in vaccine development and gene therapy is critica...
In spite of continuous development of gene therapy vectors with thousands of drug candidates in clin...
Analytical band centrifugation (ABC) was first developed for the separation of macromolecules in cen...
International audienceAlthough the clinical use of recombinant adeno-associated virus (rAAV) vectors...
Recombinant adenovirus is one of the primary vectors for human gene therapy. However, the aggregatio...
Gene therapy approaches using recombinant adeno-associated virus serotype 2 (rAAV2) and serotype 8 (...
Gene therapy approaches using recombinant adeno-associated virus serotype 2 (rAAV2) and serotype 8 (...
Removal of empty capsids from adeno-associated virus (AAV) manufacturing lots remains a critical ste...
A recombinant adeno-associated virus serotype 2 Reference Standard Material (rAAV2 RSM) has been pro...
A recombinant adeno-associated virus serotype 2 Reference Standard Material (rAAV2 RSM) has been pro...
Recombinant adeno-associated viruses (AAVs) are promising vectors for human gene therapy. However, c...
Ion-exchange chromatography coupled to light scattering detectors represents a fast and simple analy...
We observed differential infectivity and product yield between two recombinant chimpanzee adenovirus...
Recombinant adeno-associated viral vectors (rAAV) represent a gene therapy tool of ever-increasing i...
International audienceGene therapy approaches using recombinant adeno-associated virus serotype 2 (r...
Quantifying the composition of viral vectors used in vaccine development and gene therapy is critica...
In spite of continuous development of gene therapy vectors with thousands of drug candidates in clin...
Analytical band centrifugation (ABC) was first developed for the separation of macromolecules in cen...
International audienceAlthough the clinical use of recombinant adeno-associated virus (rAAV) vectors...
Recombinant adenovirus is one of the primary vectors for human gene therapy. However, the aggregatio...
Gene therapy approaches using recombinant adeno-associated virus serotype 2 (rAAV2) and serotype 8 (...
Gene therapy approaches using recombinant adeno-associated virus serotype 2 (rAAV2) and serotype 8 (...
Removal of empty capsids from adeno-associated virus (AAV) manufacturing lots remains a critical ste...
A recombinant adeno-associated virus serotype 2 Reference Standard Material (rAAV2 RSM) has been pro...
A recombinant adeno-associated virus serotype 2 Reference Standard Material (rAAV2 RSM) has been pro...
Recombinant adeno-associated viruses (AAVs) are promising vectors for human gene therapy. However, c...
Ion-exchange chromatography coupled to light scattering detectors represents a fast and simple analy...
We observed differential infectivity and product yield between two recombinant chimpanzee adenovirus...
Recombinant adeno-associated viral vectors (rAAV) represent a gene therapy tool of ever-increasing i...
International audienceGene therapy approaches using recombinant adeno-associated virus serotype 2 (r...
Quantifying the composition of viral vectors used in vaccine development and gene therapy is critica...
In spite of continuous development of gene therapy vectors with thousands of drug candidates in clin...